FASEB J. Mp Biomedicals
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SCHMID, E.
Right arrow Articles by DRÖGE, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SCHMID, E.
Right arrow Articles by DRÖGE, W.
(The FASEB Journal. 1999;13:1491-1500.)
© 1999 FASEB

Phosphorylation of the insulin receptor kinase by phosphocreatine in combination with hydrogen peroxide: the structural basis of redox priming

ELMAR SCHMID*, AGNES HOTZ-WAGENBLATT{dagger}, VOLKER HACK* and WULF DRÖGE*1

* Division of Immunochemistry and
{dagger} Division of Molecular Biophysics, Deutsches Krebsforschungszentrum, D-69120 Heidelberg, Germany

1Correspondence: Division of Immunochemistry Deutsches Krebsforschungszentrum Im Neuenheimer Feld 280 69120 Heidelberg, Germany. E-mail: W.Droege{at}dkfz-heidelberg.de


   ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
Signaling by insulin requires autophosphorylation of the insulin receptor kinase (IRK) at Tyr1158, Tyr1162, and Tyr1163. Earlier experiments with 32P-{gamma}-ATP indicated that the nonphosphorylated IRK (IRK-0P) is relatively inactive, and crystallographic data indicated that the ATP binding site of IRK-0P is blocked by its activation loop. We now show that phosphocreatine (PCr) in combination with hydrogen peroxide serves as an alternative phosphate donor and that ATP and PCr use distinct binding sites. Whereas phosphorylation of the IRK by ATP is inhibited by the nonhydrolyzable competitor adenylyl-imidodiphosphate, phosphorylation by PCr is enhanced. The IRK mutant Tyr1158Phe showed no phosphorylation with PCr but almost normal phosphorylation with ATP, whereas Tyr1162Phe was phosphorylated well with PCr but less then normal with ATP. 3-Dimensional models of IRK-0P revealed that the conversion of any of the four cysteine residues 1056, 1138, 1234, and 1245 into sulfenic acid produces structural changes that bring Tyr1158 into close contact with Asp1083 and render the well-known catalytic site at Asp1132 and Tyr1162 accessible from a direction that differs from the known ATP binding site. The mutant Cys1138Ala, in contrast, showed relatively inaccessible catalytic sites and weak catalytic activity in functional experiments. Taken together, these findings indicate that `redox priming' of the IRK facilitates its autophosphorylation by PCr in the activation loop.—Schmid, E., Hotz-Wagenblatt, A., Hack, V., Dröge, W. Phosphorylation of the insulin receptor kinase by phosphocreatine in combination with hydrogen peroxide: the structural basis of redox priming.


Key Words: insulin responsiveness • redox regulation • signal transduction • tyrosine kinase


   INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
AN ABNORMALLY LOW insulin receptor kinase (IRK)2 activity and impaired insulin responsiveness are common findings in obesity, non-insulin-dependent diabetes mellitus (NIDDM), and old age (1 2 3 4 5 6) . Early in NIDDM, insulin resistance is most pronounced in skeletal muscle, i.e., the tissue responsible for 70–90% of the glucose disposal after carbohydrate ingestion (7 8 9 10) . A muscle-specific insulin receptor (IR) knockout was shown to exhibit features of NIDDM (11) . The cause of the insulin resistance in NIDDM and old age is not known but may be related to the mechanism of IRK activation, which is also poorly understood. A large body of evidence indicated that the nonphosphorylated IRK has only weak kinase activity, but, paradoxically, autophosphorylation at Tyr1158, Tyr1162, and Tyr1163 is required for kinase activation (12 13 14 15 16 17 18 19) . It must be emphasized, however, that all studies of the catalytic activity and of the autophosphorylation of the IRK were based on experiments with 32P-{gamma}-ATP (see refs 12 13 14 15 16 17 18 19 ). This seemed justified in view of earlier studies showing that ATP is the preferred phosphate donor for most protein kinase (PK) species and that GTP, UTP, or ITP donate phosphate to a minor extent (20) . The crystal structures of several PKs, including the triple-phosphorylated insulin receptor kinase (IRK-3P) (19) , cAPK (21) , Lck (22) , c-Src (23 , 24) , Hck (25) , and FGFRK (26) , revealed structurally similar PK domains with similar ATP binding sites. The nonphosphorylated IRK (IRK-0P) showed a similar crystal structure but differed with respect to the atypical position of its `activation loop', which prevents productive ATP binding (27) . To reconcile this finding with the requirement for autophosphorylation, it was hypothesized that the induction of the catalytic activity may involve transient dislocation of the activation loop including Tyr1162 away from the catalytic site in such a way that Mg-ATP can bind to the common ATP binding site and have contact to the catalytic site (27) . This catalytic site could then engage in trans-autophosphorylation.

However, because Tyr1162 is located in the original IRK-0P structure in a position next to the catalytic amino acid Asp1132 (27) , this configuration seems ideally suited for cis-autophosphorylation. In this study, therefore, we considered the alternative possibility that an unidentified phosphate donor may bind to a site different from the common ATP binding site and phosphorylate Tyr1162 without requiring the dislocation of the activation loop. To test this hypothesis, we studied alternative phosphate donors and focused on the predominant skeletal muscle phosphagen phosphocreatine (PCr). Because autophosphorylation of the IR was previously shown to be facilitated by hydrogen peroxide (HP) (28 29 30 31 32) and strongly enhanced by procedures that decrease intracellular levels of glutathione (GSH) (33) , we pretreated the cells with buthionine sulfoximine (BSO), a specific inhibitor of GSH biosynthesis (34) , and treated the immunoprecipitated IR routinely with HP.


   MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
Cells and cell culture conditions
Chinese hamster ovary (CHO) cells or CHO cells stably transfected with wild-type IR (CHO-HIR) (35) or with the IR mutants Tyr1158Phe or Tyr1162Phe (36) (kindly provided by Dr. T. Pillay, University of Nottingham Medical School, Nottingham, U.K., and Dr. P. Wilden, University of Iowa) were cultured in F12 medium with 10% fetal calf serum, glutamine, and antibiotics to total confluence and moderately starved in order to decrease intracellular PCr level. For the last 17 h before lysis, the cells were further cultured in serum-free modified NCTC 135 medium (37) in the presence of 30 µM BSO (Sigma, St. Louis, Mo.).

Transient transfection of CHO cells
CHO cells were transiently transfected with pECE expression vectors containing either wild-type human IR or IR cDNA containing the single ß chain mutations Cys981Ala, Cys1056Ala, Cys1138Ala, Cys1234Ala, Cys1245Ala, and Cys1308Ala (38) (kindly provided by Dr. C. W. Ward, CPIRO, Parkville, Australia). We confirmed the catalytically inactive Cys1138Ala mutation by DNA sequencing. In addition, Xbal-BamHI fragments were prepared to confirm the wild-type and mutated hIR DNA. Transfection was done with 2 µg wild-type or mutant DNA by using the Lipofectamine technique (Gibco BRL, Grand Island, N.Y.) according to the manufacturer's protocol. After incubation for 48 h in F12 medium, the cells were incubated for an additional 17 h in serum-free modified NCTC135 medium containing 30 µM BSO.

Insulin stimulation, cell lysis, IR precipitation, in vitro kinase assay, and detection of tyrosine phosphorylation
The cells were finally washed with cold phosphate-buffered saline/0.4 mM EDTA and lysed with 0.1% sodium dodecyl sulfate (SDS) and 0.1% DOC, as described previously (33) The IR was immunoprecipitated with the monoclonal hIR ß chain-specific antibody Ab-1 (Oncogene Science, Uniondale, N.Y.) and washed as described (33) . If indicated, the immunoprecipitates were then incubated with 3 or 100 nM human recombinant insulin (Sigma) for 30 min on ice. After pelleting, the immune complexes were further incubated for 20 min at 30°C in kinase buffer (33) without manganese chloride either with graded concentrations of PCr (Sigma), 2 mM phosphoenol pyruvate (Sigma), 100 µM ATP (Sigma), or other nucleotides in the presence of 25 µM HP (Merck; Darmstadt, Germany) unless indicated otherwise. The immune complexes were finally washed with ice-cold kinase buffer and subjected to SDS-polyacrylamide gel electrophoresis (PAGE) and Western blotting. After probing for tyrosine phosphorylation with the monoclonal antiphosphotyrosine antibody 4G10 (Upstate Biotechnology, Lake Placid, N.Y.; BioMol, Hamburg, Germany), IR expression was determined with a polyclonal anti-ßIR antibody (Santa Cruz Biotechnology, Heidelberg) as described (33) . In some cases the immunoprecipitates were subjected to the in vitro kinase assay (incorporation of 32P-{gamma}-ATP), as described elsewhere (33) , and again probed for IR expression.

3-Dimensional modeling of the nonphosphorylated IR ß chain and of derivatized proteins
The 3-dimensional structures of the IRK domain and its derivatives were modeled on an Indigo II workstation (Silicon Graphics). The starting coordinates of nonhydrogen atoms were taken from the Protein Data Bank entry 1irk (27) . Atoms not reported in Protein Data Bank 1irk were inserted with the help of the INSIGHT II library and hydrogen atoms were added. This structure was the basis for all subsequent modifications. Energy minimization was performed on an IBM-SP2 workstation using the DISCOVER module of the INSIGHT II program (Molecular Simulation BIOSYM Technologies Inc.) and the conjugate gradient method for energy minimization. The generation of hydrogen atoms and the automatic assignment of atom potential types and partial charges were achieved using the consistent valence force field (39) . The polar amino acids of the molecule were in the uncharged form and a dielectric constant of 1 was used, because the water in the electrostatic environment was expected to inhibit interactions at the surface. During the first 100 steps of minimization, only the hydrogen atoms were allowed to move in order to avoid large forces at the backbone just because of the newly added hydrogens. For the next 100 steps, all C{alpha} atoms were tethered using a harmonic potential with the force constant of 100 kJ. Full minimization of all atoms was carried out until the maximum force value reached a value below 0.001. The figures of the minimized structures were obtained by RASMOL (Roger Sayle).


   RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
IRK phosphorylation by PCr: role of hydrogen peroxide
Immunoprecipitated IR from CHO cells stably transfected with hIR DNA (CHO-HIR) (35) was prepared and incubated with insulin and either 0.1 mM ATP, GTP, UTP, CTP, 2 mM phosphoenolpyruvate or 1–40 mM PCr in combination with 25 µM HP as described in Materials and Methods. The resulting tyrosine phosphorylation was then determined with the anti-phosphotyrosine antibody 4G10. Experiments with the most abundant mammalian phosphagen (i.e., PCr) revealed that tyrosine phosphorylation of the IRß chain does indeed occur at physiologically relevant concentrations of 5–40 mM PCr in the presence, but not in the absence, of HP (Fig. 1 A, B). When CHO cells were transiently transfected in parallel with hIR DNA or DNA from the structurally related src family kinase fynB, PCr-dependent tyrosine phosphorylation was seen in the IR but not in the fyn protein (Fig. 1C ).



View larger version (26K):
[in this window]
[in a new window]
 
Figure 1. Phosphocreatine (PCr) mediates autophosphorylation of the IR ß chain but not of fynB. A, B) CHO-HIR cells were cultured in F12 medium with 10% fetal calf serum, glutamine, and antibiotics to total confluence, then for 17 h in serum-free modified NCTC 135 medium (37) with 30 µM BSO (Sigma), and finally lysed. The IR was immunoprecipitated with the monoclonal hIR ß chain antibody Ab-1 (Oncogene Science) (33) . The immunoprecipitates were incubated on ice with 100 nM insulin for 30 min in kinase buffer (33) without manganese chloride and centrifuged. The pellet was incubated for 20 min at 30°C in the same kinase buffer with graded concentrations of PCr or 100 µM ATP (Sigma) in the presence of 25 µM hydrogen peroxide (H2O2) (Merck) unless indicated otherwise. The immune complexes were finally washed with ice-cold kinase buffer, subjected to SDS-PAGE and Western blotting, and probed for tyrosine phosphorylation with the monoclonal antiphosphotyrosine antibody 4G10 (Upstate Bio/Technology Inc., BioMol, Hamburg, Germany) and for IR expression with a polyclonal anti-ßIR antibody (Santa Cruz Biotechnology) as described (33) . C) CHO cells were transiently transfected with 2 µg of wild-type hIR DNA (left panel) or fynB DNA (kindly provided by Dr. Sarah Courtneidge-Sugen, Redwood City, Calif.), cultured, and lysed as described above. The immunoprecipitated proteins were incubated either with 0.1 mM ATP or 5 mM PCr and probed for phosphotyrosine and IR or fyn expression, respectively. A and P indicate ATP and PCr, respectively.

A substantial degree of IRK phosphorylation was also seen with other nucleotides and phosphoenolpyruvate. However, in all these cases (not shown) as well as in the case of ATP (Fig. 2 ), phosphorylation was inhibited by the nucleotide analog adenylyl-imidodiphosphate (AMP-PNP). Phosphorylation by PCr, in contrast, was enhanced by AMP-PNP. With the relatively low concentration of 3 nM insulin (Fig. 2) or in the absence of insulin (Fig. 3 ), the PCr-dependent IRK phosphorylation was barely detectable without AMP-PNP but quite substantial in the presence of AMP-PNP. In the phosphorylated IRK, AMP-PNP binds to the adenosine binding site (19) and therefore competitively inhibits the phosphorylation by ATP or other phosphate donors that bind to this site. In the nonphosphorylated IRK, in contrast, the activation loop separates the adenosine binding groove from the catalytic site (27) . In this case, binding of AMP-PNP to the adenosine binding groove would be expected not to interfere with the binding of another phosphate donor to the catalytic site. The enhancement of the PCr-dependent phosphorylation by AMP-PNP therefore suggested that 1) PCr is not acting via the ATP binding site, 2) PCr is most probably involved in the initial phosphorylation of the nonphosphorylated IRK, and 3) the PCr-dependent phosphorylation may be synergistically enhanced by an adenosine nucleotide. This possibility remains to be investigated.



View larger version (27K):
[in this window]
[in a new window]
 
Figure 2. Failure of adenyl-imidodiphosphate (AMP-PNP) to inhibit the PCr-dependent autophosphorylation. IR immunoprecipitates were incubated with 3 nM insulin for 30 min on ice, then pelleted and incubated for 10 min at room temperature with or without 5 mM AMP-PNP (Boehringer-Mannheim, Mannheim, Germany) in kinase buffer without manganese chloride. They were pelleted again and incubated for 20 min at 30°C with 25 µM HP and graded concentrations of PCr or 0.1 mM ATP, as indicated.



View larger version (42K):
[in this window]
[in a new window]
 
Figure 3. Differential PCr- and ATP-dependent phosphorylation of IRK mutant proteins. Immunoprecipitates from wild-type and mutant IRK proteins were tested for PCr-dependent (5 mM) and ATP-dependent autophosphorylation without prior insulin treatment. For other details, see legend to Fig. 2 . A and P indicate ATP and phosphocreatine.

Failure of PCr to phosphorylate the IRK mutant Tyr1158Phe
To determine whether PCr may phosphorylate preferentially or exclusively Tyr1162 (see opening paragraphs), we studied CHO cells stably transfected with DNA from the hIR mutant Tyr1162Phe. CHO cells transfected with the mutant Tyr1158Phe and wild-type IRK were included as controls. These experiments confirmed and extended previous studies (36) showing that the ATP-dependent phosphorylation was strongly decreased in the case of the mutant Tyr1162Phe but, on average in our experiments, only moderately decreased in the case of Tyr1158Phe (Fig. 3A ). The PCr-dependent phosphorylation, in contrast, was clearly detectable in the case of the Tyr1162Phe mutant but undetectable in the case of the Tyr1158Phe mutant. This finding led to the unexpected conclusion that Tyr1158 rather than Tyr1162 may serve as the (primary) PCr-dependent phosphorylation sites. AMP-PNP enhanced PCr-dependent phosphorylation of the wild-type IRK but not of the two mutant proteins (Fig. 3B ).

The structural basis of `redox priming'
The conclusion that Tyr1158 serves as the primary target of the PCr-dependent phosphorylation was not easily reconciled with the calculated distance between Tyr1158 and the nearest aspartate group. In the activated IRK-3P protein (19) , the hydroxyl group of the substrate tyrosine is in close contact with the carboxylate group of the catalytic amino acid Asp1132 (O{eta}-O{delta}2:2.7 Å). A similar distance of 2.6 Å was found between O{eta} of Tyr1162 and O{delta}2 of Asp1132 in the nonphosphorylated IRK structure (27) (see also Fig. 4 A). In contrast, the computed distance between O{eta} of Tyr1158 (gray ring in the center of Fig. 5 A) and the carboxylate group (light blue) of the nearest aspartate (Asp1083) in the 3-dimensional model of the nonphosphorylated IRK structure (1irk without mercury; see Materials and Methods) is greater than 4 Å (Table 1 ). Therefore, we used 3-dimensional modeling of derivatized IRK protein structures to determine whether the interaction of the IRK with HP may cause a structural alteration that moves the hydroxyl group of Tyr1158 into the proper distance of the carboxylate group of Asp1083.



View larger version (99K):
[in this window]
[in a new window]
 
Figure 4. A) 3-Dimensional model of the wild-type IR ß chain obtained from 1irk by deleting the two ethyl-mercury groups and subsequent energy minimization. The sequence beyond Lys1264 has been deleted because it is relatively unstructured and expected to be flexible in solution. The 3-dimensional model is shown from three different angles. The left panel shows the catalytic site (with Tyr1162 C in gray, O in red, N in blue, H in white) in the upper right corner and its OH group pointing toward the center. The middle panel shows a view in the direction of the long axis of Tyr1162 (center); the right panel shows the view into the catalytic site (i.e., the putative PCr binding site with Tyr1162 on the left side pointing to the center). Also shown are the catalytic amino acid Asp1132 next to Tyr1162, the Cys residues 1056, 1138, 1234, and 1245, Glu1047 (white), Asn1137 (flesh tone), and Arg1243 (dark blue). Parts of the backbone are blue (996–1031), yellow (1038–1066), green (1106–1125), flesh tone (1126–1145 including the catalytic loop), orange (1146–1171 including the activation loop), light gray (1188–1235), and pink (1236–1245). B) Superposition of the sulfenic acid derivatives 1056CyS-OH, 1138CyS-OH, 1234CyS-OH, 1245CyS-OH. The micrograph x picture publisher was used to superimpose the figures exported by RASMOL. For other details, see upper panel. C–E) View on the surface of the putative PCr binding site corresponding to the upper right panels. The guanido groups of Arg1039 and Arg1131 are red and the carboxyl groups of Glu1043, Glu1047, and Asp1150 are dark blue. The carboxyl group of the catalytic amino acid Asp1132 is light blue. Its contact to the hydroxyl group of Tyr1162 is marked by a green cross.



View larger version (105K):
[in this window]
[in a new window]
 
Figure 5. The vicinity of Tyr1158 on the surface of the IRß chain. In the center is Tyr1158 (C in gray, O in red, N in blue, H in white). Next to its hydroxyl group (pointing to the left side) is the putative catalytic amino acid Asp1083, with its carboxylate group in blue. The figure also shows the Cys residues 1234 and 1245 (S in yellow), Arg1000 (its guanido group stained red to indicate the surface charge), Ile1157 in orange, Arg1136 and Met1139 in flesh tone, Glu1001 and Leu1002 in cyan (the carboxylate group of Glu1001 in dark blue to indicate the surface charge), Glu1077, Leu1078, Met1079, His1081, Glu1082, Lys1085, Ser1086, and Arg1089 in green (the guanido group of Arg1089 again in red). Cys1056 and 1138 are hidden. Parts of the backbone are again stained as in Fig. 4 A.


View this table:
[in this window]
[in a new window]
 
Table 1. Computed distance between the hydroxyl group of Tyr1158 and the carboxylate group of Asp1083 in various IRK derivatives and mutant proteinsa

Because HP was previously shown to convert cysteine residues into cysteine-sulfenic acid derivatives (CyS-H + H2O2 -> CyS-OH + H2O; see refs 40 , 41 ), we determined the 3-dimensional structure of the various sulfenic acid derivatives of the IR-ß chain by molecular modeling and energy minimization. The structure `1irk w/o mercury' (Fig. 4A ) was obtained from the 3-dimensional structures of the IRK domain (27) (1irk; not shown here) by removing the ethyl-mercury groups and by subsequent energy minimization. The 3-dimensional structures Ser981Cys and 981 CyS-OH (not shown) obtained by replacing serine 981 with the authentic cysteine and cysteine-sulfenic acid, respectively, followed by energy minimization, had essentially the same structure as `1irk w/o mercury'. In contrast, the four derivatives 1056 CyS-OH, 1138 CyS-OH, 1234 CyS-OH, and 1245 Cys-OH showed conspicuous structural changes (Fig. 4B and Fig. 5B-E ). These four sulfenic acid derivatives had almost identical 3-dimensional structures, as illustrated by the superposition in Fig. 4B . Each of these four derivatizations moved the hydroxyl group of Tyr1158 into close contact with the carboxylate group of Asp1083 (O{eta}-O{delta}2:2.8–2.9 Å, see Table 1 and Fig. 5 ) and rendered the catalytic center at Asp1132 accessible from a direction opposite to that of the common ATP binding site (Fig. 4) . The accessibility of the carboxylate group of the catalytic amino acid Asp1132 and the adjacent hydroxyl group of Tyr1162 together with the positive and negative charges at the surface in the vicinity of this catalytic center are shown in Fig. 4C-E . The 3-dimensional models of the nitric oxide derivatives 1234 CyS-NO (Fig. 5F ), 1056 CyS-NO, 1138 CyS-NO, and 1245 CyS-NO (not shown) were similar to the structures of the sulfenic acid derivatives. The structures of the mutants Cys1234Ala (Fig. 5G ), Cys1245Ala, and Cys1056Ala (not shown) were also similar to the corresponding CyS-OH derivatives, whereas Cys1138Ala (not shown) and the 1234 CyS-OH derivative of Cys1138Ala (Fig. 4E , Fig. 5H ) had inaccessible catalytic sites.

Defective PCr-dependent and ATP-dependent phosphorylation of the IRK mutant Cys1138Ala
Experiments with CHO cells (Fig. 6 ) and NIH-3T3 cells (not shown) transiently transfected with DNA from the hIR mutant Cys1138Ala confirmed the prediction from the 3-dimensional modeling that this mutant is poorly autophosphorylated by PCr and ATP, although the protein is clearly expressed. Essentially similar results were obtained if the phosphorylation reaction was performed in the presence of 5 mM AMP-PNP and with 3 µM insulin (not shown). Cells transiently transfected with the wild-type or other Cys->Ala mutants, in contrast, showed strong tyrosine phosphorylation (Fig. 6) and kinase activity with 32P-{gamma}-ATP (not shown). These differences were not detected in a previous study of these mutants (38) . It is conceivable that in this previous study the endogenous IR of the host cell might have contributed to the functions under test.



View larger version (31K):
[in this window]
[in a new window]
 
Figure 6. Defective kinase activity of the IR mutant Cys1138Ala. A) CHO cells were transiently transfected with 2 µg wild-type or mutant DNA by the Lipofectamine technique (Gibco BRL, manufacturer's protocol), incubated for 48 h in F12 medium plus 17 h in modified NCTC135 medium with or without 100 nM insulin, and lysed. Immunoprecipitates were probed for tyrosine phosphorylation and IR expression as described in the legend to Fig. 1 . B) The immunoprecipitates were subjected to the in vitro kinase assay with 32P-{gamma}-ATP (33) and probed for IR expression. Similar results were seen 72 h after transfection and with transfected NIH3T3 fibroblasts grown in DMEM (not shown). C) Immunoprecipitated IR from transfected CHO cells was incubated sequentially with 100 nM insulin and 5 mM PCr or 0.1 mM ATP in the presence of 25 µM HP and probed for tyrosine phosphorylation and IR expression, as described in the legend to Fig. 1 .


   DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 
Our studies show for the first time that a tyrosine kinase uses PCr as a phosphate donor. The failure of AMP-PNP to inhibit the PCr-dependent IRK phosphorylation and the published crystal structures of IRK-0P and IRK-3P (19 , 27) , together with our 3-dimensional models, suggest that the IRK exposes sequentially different binding sites for different phosphate donors. The enhancing effect of AMP-PNP indicates, moreover, that a physiological adenosine nucleotide may serve as a positive allosteric regulator of the PCr-dependent phosphorylation. Regardless of whether this possibility will be confirmed or not, AMP-PNP appears to generate a steric effect similar to that induced by insulin or by the mutation Tyr1162Phe. AMP-PNP, insulin, or said mutation were all found to enhance the PCr-dependent IRK phosphorylation independent of each other. In agreement with these findings, the mutant Tyr1162Phe was previously shown to express a relatively high baseline kinase activity that was not significantly increased by insulin (42) .

In addition, our studies provide a structural explanation for the widely observed stimulating effects of oxidants (28 29 30 31 32) and the effects of SH-reactive reagents on the catalytic activity of the IRK (43 44 45) . It may be important in this context that HP production can also be induced among others by insulin (46) . The effect of HP is best explained by the prediction of the 3-dimensional models that oxidation of any one of several critical cysteine residues by HP may increase the competence of the kinase to autophosphorylate the activation loop at Tyr1158 and Tyr1162. A comparison of Fig. 4A, B and Fig. 5A-E suggests that cysteine residues at four different positions of the IRK domain share the function of preventing the spontaneous autophosphorylation at Tyr1158 and Tyr1162 and that derivatization of anyone of these residues by HP activates both catalytic sites. This effect of HP is therefore proposed to account for the enhancement of IRK activity by HP as reported previously (28 29 30 31 32) .

The failure of PCr to phosphorylate the mutant Tyr1158Phe indicates that Tyr1158 is the first and limiting target. However, the possibility that Tyr1162 is also phosphorylated by PCr is not formally excluded. If so, the PCr-dependent phosphorylation of Tyr1162 would appear to depend strictly on the prior phosphorylation of Tyr1158. Three-dimensional modeling of the IRK structure monophosphorylated at Tyr1158 indeed showed a slightly better accessibility of Tyr1162/Asp1132 than the sulfenic acid derivatives, as illustrated by the wide open angle between the {alpha}-helix C (yellow) and the activation loop (orange) in Fig. 5I . The view into the putative binding site of the phosphate donor (not shown) is essentially similar to that of 1234-Cys-OH (Fig. 4D ). Earlier studies of the autophosphorylation of the IRK provided no explanation for the physiological function of Tyr1158 (19) . It was noted, however, that the ATP-dependent phosphorylation of the mutant Tyr1158Phe is only moderately decreased on the average of our experiments (see also ref 36 ) despite the complete abrogation of the PCr-dependent phosphorylation. Whether the induction of the ATP-dependent catalytic activity of the wild-type IRK, in contrast to the mutant Tyr1158Phe, has a strict requirement for an initial PCr-dependent phosphorylation of Tyr1158 or whether the alternative mechanism proposed by Hubbard et al. (see opening paragraphs) may operate to some extent remains to be determined. There is the interesting possibility that both modes of phosphorylation have different functional consequences. A similar sequence of phosphorylation events may also be involved in the activation of the closely related nerve growth factor receptor tyrosine kinase, which contains three functionally important tyrosine groups (Tyr670, Tyr674, and Tyr675) in the activation loop (47 48 49) .

The most important physiological implication of the PCr-dependent phosphorylation of the IRK may be that the muscle tissue gains an advantage over the liver with regard to insulin-induced fuel deposition. In contrast to the rather strong cytoplasmic and mitochondrial creatine kinase activity and high PCr levels in the skeletal muscle tissue, the liver has little or no creatine kinase activity (50 , 51) . Mitochondrial creatine kinase has been found in human liver by some authors (50) but not by others (51) . It is therefore conceivable that the PCr-dependent IRK phosphorylation may give the insulin-induced muscular glycogen and protein synthesis priority over the utilization of glucose and amino acids in the hepatic lipogenesis. If so, a decrease in the muscular PCr-dependent IRK phosphorylation may favor obesity.

Insulin-stimulated kinase activity was previously shown to be markedly compromised in NIDDM and obesity (1 , 2) , and physical exercise was shown to increase insulin responsiveness in NIDDM (52 53 54) . The mechanism, however, remained obscure. Our studies now suggest that this effect may be mediated by reactive oxygen intermediates that may be increased at least temporarily by physical exercise (55 56 57 58 59) . Skeletal muscle type II fibers with relatively fast contraction times were found to have substantially lower intracellular GSH levels than type I fibers (60) . Last but not least, the HP scavenging enzymes catalase and glutathione peroxidase were shown to increase significantly with age in rat skeletal muscle (61 , 62) . In view of these facts, the findings in this report may lead to new strategies to ameliorate the decrease in insulin responsiveness that often accompanies NIDDM, obesity, cancer cachexia, and old age and may have implications also for sports medicine.


   ACKNOWLEDGMENTS
 
We thank Dr. S. Suhai for help in modeling the 3-dimensional structures and Dr. A. Ushmorov for constructive comments. We also thank Ms. Ott-Hartmann and Ms. N. Erbe for technical assistance and Ms. I. Fryson for assistance in preparing the manuscript. This work was funded by the Deutsche Forschungsgemeinschaft.


   FOOTNOTES
 
2 Abbreviations: AMP-PNP, adenylyl-imidodiphosphate; BSO, buthionine sulfoximine; CHO, Chinese hamster ovary; GSH, glutathione; HP, hydrogen peroxide; IR, insulin receptor; IRK, insulin receptor kinase; IRK-0P, nonphosphorylated IRK; IRK-3P, triple-phosphorylated insulin receptor kinase; NIDDM, non-insulin-dependent diabetes mellitus; PCr, phosphocreatine; PK, protein kinase; SDS-PAGE, sodium dodecyl sulfate-polyacrylamide gel electrophoresis.

Received for publication February 8, 1999. Accepted for publication without revision March 19, 1999.


   REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
 

  1. Freidenberg, G. R., Henry, R. R., Klein, H. H., Reichart, D. R., Olefsky, J. (1987) Decreased kinase activity of insulin receptors from adipocytes of non-insulin-dependent diabetic subjects. J. Clin. Invest. 79,240-250
  2. Takayama, S., Kahn, C. R., Kubo, K., Foley, J. E. (1988) Alterations in insulin receptor autophosphorylation in insulin resistance: Correlation with altered sensitivity to glucose transport and antilipolysis to insulin. J. Clin. Endocrinol. Metab. 66,992-999[Abstract/Free Full Text]
  3. Damsbo, P., Vaag, A., Hother-Nielsen, O., Beck-Nielsen, H. (1991) Reduced glycogen synthase activity in skeletal muscle from obese patients with and without type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 34,239-245[Medline]
  4. Cahill, G. F., Jr (1971) The Banting Memorial Lecture 1971. Physiology of insulin in man. Diabetes 20,785-799
  5. Fukagawa, N. K., Minaker, K. L., Young, V. R., Matthews, D. E., Bier, D. M., Rowe, J. W. (1989) Leucine metabolism in aging humans: effect of insulin and substrate availability. Am. J. Physiol. 256,E288-E294[Abstract/Free Full Text]
  6. Carvalho, C. R., Brenelli, S. L., Silva, A. C., Nunes, A. L., Velloso, L. A., Saad, M. J. (1996) Effect of aging on insulin receptor, insulin receptor substrate-1, and phosphatidylinositol 3-kinase in liver and muscle of rats. Endocrinology 137,151-159[Abstract]
  7. Martin, B. C., Warram, J. H., Krolewski, A. S., Bergman, R. N., Soeldner, J. S., Kahn, C. R. (1992) Role of glucose and insulin resistance in development of type II diabetes mellitus: results of a 25-year follow-up study. Lancet 340,925-929[Medline]
  8. Lillioja, S., Mott, D. M., Spraul, M., Ferraro, R., Foley, J. E., Ravussin, E., Knowler, W. C., Bennett, P. H., Bogardus, C. (1993) Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus: prospective studies of Pima Indians. N. Engl. J. Med. 329,1988-1992[Abstract/Free Full Text]
  9. Kahn, C. R. (1994) Insulin action, diabetogenes, and the cause of type II diabetes (Banting lecture). Diabetes 43,1066-1084[Medline]
  10. DeFronzo, R. A. (1997) Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying diabetes genes. Diabetes Rev 5,177-269
  11. Brüning, J. C., Michael, M. D., Winnay, J. N., Hayashi, T., Hörsch, D., Accili, D., Goodyear, L. J., Kahn, C. R. (1998) A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol. Cell 2,559-569[Medline]
  12. Rosen, O. M., Herrera, R., Olowe, Y., Petruzzelli, L. M., Cobb, M. H. (1983) Phosphorylation activates the insulin receptor tyrosine protein kinase. Proc. Natl. Acad. Sci. USA 80,3237-3240[Abstract/Free Full Text]
  13. Lee, J., Pilch, P. F. (1994) The insulin receptor: structure, function, and signaling. Am. J. Physiol. 266,C319-C334[Abstract/Free Full Text]
  14. Taylor, S. S., Radzio-Andzelm, E., Hunter, T. (1995) How do protein kinases discriminate between serine/threonine and tyrosine?. Structural insights from the insulin receptor protein-tyrosine kinase. FASEB J. 9,1255-1266[Abstract]
  15. White, M. F., Shoelson, S. E., Keutmann, H., Kahn, C. R. (1988) A cascade of tyrosine autophosphorylation in the ß-subunit activates the phosphotransferase of the insulin receptor. J. Biol. Chem. 263,2969-2980[Abstract/Free Full Text]
  16. Flores-Riveros, J. R., Sibley, E., Kastelic, T., Lane, M. D. (1989) Substrate phosphorylation catalyzed by the insulin receptor tyrosine kinase. J. Biol. Chem. 264,21557-21572[Abstract/Free Full Text]
  17. Dickens, M., Tavaré, J. M. (1992) Analysis of the order of autophosphorylation of human insulin receptor tyrosines 1158, 1162 and 1163. Biochem. Biophys. Res. Commun. 186,244-250[Medline]
  18. Wei, L., Hubbard, S. R., Hendrickson, W. A., Ellis, L. (1995) Expression, characterization, and crystallization of the catalytic core of the human insulin receptor protein-tyrosine kinase domain. J. Biol. Chem. 270,8122-8130[Abstract/Free Full Text]
  19. Hubbard, S. R. (1997) Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog. EMBO J 16,5572-5581[Medline]
  20. Flockhart, D. A., Corbin, J. D. (1982) Regulatory mechanisms in the control of protein kinases. Crit. Rev. Biochem. 12,133-186[Medline]
  21. Zheng, J., Knighton, D. R., Xuong, N. H., Taylor, S. S., Sowadski, J. M., Ten, E. L. (1993) Crystal structures of the myristylated catalytic subunit of cAMP-dependent protein kinase reveal open and closed conformations. Protein Sci 2,1559-1573[Medline]
  22. Yamaguchi, H., Hendrickson, W. A. (1996) Structural basis for activation of human lymphocyte kinase Lck upon tyrosine phosphorylation. Nature (London) 384,484-489[Medline]
  23. Xu, W., Harrison, S. C., Eck, M. J. (1997) Three-dimensional structure of the tyrosine kinase c-Src. Nature (London) 385,595-602[Medline]
  24. Williams, J. C., Weijland, A., Gonfloni, S., Thompson, A., Courtneidge, S. A., Superti-Furga, G., Wierenga, R. K. (1997) The 2.35 Å crystal structure of the inactivated form of chicken Src: a dynamic molecule with multiple regulatory interactions. J. Mol. Biol. 274,757-775[Medline]
  25. Sicheri, F., Moarefi, I., Kuriyan, J. (1997) Crystal structure of the Src family tyrosine kinase Hck. Nature (London) 385,602-609[Medline]
  26. Mohammadi, M., Schlessinger, J., Hubbard, S. R. (1996) Structure of the FGF receptor tyrosine kinase domain reveals a novel autoinhibitory mechanism. Cell 86,577-587[Medline]
  27. Hubbard, S. R., Wei, L., Ellis, L., Hendrickson, W. A. (1994) Crystal structure of the tyrosine kinase domain of the human insulin receptor. Nature (London) 372,746-754[Medline]
  28. Kadota, S., Fantus, I. G., Deragon, G., Guyda, H. J., Posner, B. I. (1987) Stimulation of insulin-like growth factor II receptor binding and insulin receptor kinase activity in rat adipocytes. J. Biol. Chem. 262,8252-8256[Abstract/Free Full Text]
  29. Hayes, G. R., Lockwood, D. H. (1987) Role of insulin receptor phosphorylation in the insulinomimetic effects of hydrogen peroxide. Proc. Natl. Acad. Sci. USA 84,8115-8119[Abstract/Free Full Text]
  30. Koshio, O., Akanuma, Y., Kasuga, M. (1988) Hydrogen peroxide stimulates tyrosine phosphorylation of the insulin receptor and its tyrosine kinase activity in intact cells. Biochem. J. 250,95-101[Medline]
  31. Heffetz, D., Bushkin, I., Dror, R., Zick, Y. (1990) The insulinomimetic agents H2O2 and vanadate stimulate protein tyrosine phosphorylation in intact cells. J. Biol. Chem. 265,2896-2902[Abstract/Free Full Text]
  32. Fantus, G., Kadota, S., Deragon, G., Foster, B., Posner, B. I. (1989) Pervanadate (peroxide(s) of vanadate) mimics insulin action in rat adipocytes via activation of the insulin receptor tyrosine kinase. Biochemistry 28,8864-8871[Medline]
  33. Schmid, E., El Benna, J., Galter, D., Klein, G., Dröge, W. (1998) Redox priming of the insulin receptor ß chain associated with altered tyrosine kinase activity and insulin responsiveness in the absence of tyrosine autophosphorylation. FASEB J 12,863-870[Abstract/Free Full Text]
  34. Griffith, O., Meister, A. (1979) Potent and specific inhibitor of glutathione synthesis by buthionine sulfoximine (S-n-butyl-homocysteine sulfoximine). J. Biol. Chem. 254,7558-7560[Abstract/Free Full Text]
  35. Ebina, Y., Ellis, L., Jarnagin, K., Edery, M., Graf, L., Clauser, E., Ou, J.-H., Masiarz, F., Kann, Y. W., Goldfine, I. D., Roth, R. A., Rutter, W. (1985) The human insulin receptor cDNA: the structural basis for hormone-activated transmembrane signalling. Cell 40,747-758[Medline]
  36. Wilden, P. A., Kahn, C. R., Siddle, K., White, M. F. (1992) Insulin receptor kinase domain autophosphorylation regulates receptor enzymatic function. J. Biol. Chem. 267,16660-16668[Abstract/Free Full Text]
  37. Eck, H.-P., Gmünder, H., Hartmann, M., Petzoldt, D., Daniel, V., Dröge, W. (1989) Low concentrations of acid soluble thiol (cysteine) in the blood plasma of HIV-1 infected patients. Biol. Chem. Hoppe-Seyler 370,101-108[Medline]
  38. Macaulay, S. L., Polites, M., Frenkel, M. J., Hewish, D. R., Ward, C. W. (1995) Mutagenic structure/function analysis of the cytoplasmic cysteines of the insulin receptor. Biochem. J. 306,811-820
  39. Hagler, A. T., Lifson, S. (1974) Energy functions for peptides and proteins. II. The amide hydrogen bond and calculation of amide crystal properties. J. Am. Chem. Soc. 96,5327-5335
  40. Poole, L. B., Claiborne, A. (1989) The non-flavin redox center of the streptococcal NADH peroxidase. II. Evidence for a stabilized cysteine-sulfenic acid. J. Biol. Chem. 264,12330-12338[Abstract/Free Full Text]
  41. Choi, H.-J., Kang, S. W., Yang, C.-H., Rhee, S. G., Ryu, S.-E. (1998) Crystal structure of a novel human peroxidase enzyme at 2.0 Å resolution. Nature Struct. Biol. 5,400-406[Medline]
  42. Ellis, L., Clauser, E., Morgan, D. O., Edery, M., Roth, R. A., Rutter, W. J. (1986) Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin-stimulated kinase activity and uptake of 2-deoxyglucose. Cell 45,721-732[Medline]
  43. Wilden, P. A., Pessin, J. E. (1987) Differential sensitivity of the insulin-receptor kinase to thiol and oxidizing agents in the absence and presence of insulin. Biochem. J. 245,325-331[Medline]
  44. Bernier, M., Nadiv, O., Kole, H. K. (1995) Thiol-specific biotinylation of the insulin receptor in permeabilized cells enhances receptor function. Biochemistry 34,8357-8364[Medline]
  45. Clark, S., Konstantopoulos, N. (1993) Sulphydryl agents modulate insulin- and epidermal growth factor (EGF) receptor kinase via reaction with intracellular receptor domains: differential effects on basal versus activated receptors. Biochem. J. 292,217-223
  46. Krieger-Brauer, H., Medda, P. K., Kather, H. (1997) Insulin-induced activation of NADPH-dependent H2O2 generation in human adipocyte plasma membranes is mediated by G{alpha}i2. J. Biol. Chem. 272,10135-10143[Abstract/Free Full Text]
  47. Stephens, R. M., Loeb, D. M., Copeland, T. D., Pawson, T., Greene, L. A., Kaplan, D. R. (1994) TrK receptors use redundant signal transduction pathways involving SHC and PLC{gamma}-1 to mediate neuritogenesis. Neuron 12,1-20[Medline]
  48. Segal, R. A., Bhattacharyya, A., Rua, L. A., Alberta, J. A., Stephens, R. M., Kaplan, D. R., Stiles, C. D. (1996) Differential utilization of Trk autophosphorylation sites. J. Biol. Chem. 271,20175-20181[Abstract/Free Full Text]
  49. Cunningham, M. E., Greene, L. A. (1998) A function–structure model for NGF-activated TRK. EMBO J 17,7282-7293[Medline]
  50. Kanemitsu, F., Kawanishi, I., Mizushima, J. (1982) Characteristics of mitochondrial creatine kinases from normal human heart and liver tissues. Clin. Chim. Acta 119,307-317[Medline]
  51. Wallimann, T., Hemmer, W. (1994) III-2 creatine kinase in non-muscle tissues and cells. Mol. Cell. Biochem. 133/134,193-220
  52. King, D. S., Baldus, P. J., Sharp, R. L., Kesl, L. D., Feltmeyer, T. L., Riddle, M. S. (1995) Time course for exercise-induced alterations in insulin action and glucose tolerance in middle-aged people. J. Appl. Physiol. 78,17-22[Abstract/Free Full Text]
  53. Schneider, S. H., Khachadurian, A. K., Amorosa, L. F., Clemow, L., Rudeman, N. B. (1992) Ten-year experience with an exercise-based outpatient life-style modification program in the treatment of diabetes mellitus. Diabetes Care 15,1800-1810[Abstract]
  54. Wallberg-Henriksson, H. (1992) Exercise and diabetes mellitus. Exer. Sport Sci. Rev. 20,339-368[Medline]
  55. Sen, C. K., Atalay, M., Hänninen, O. (1994) Exercise-induced oxidative stress: glutathione supplementation and deficiency. J. Appl. Physiol. 77,2177-2187[Abstract/Free Full Text]
  56. Lew, H. L., Pyke, S., Quintanilha, A. (1985) Changes in the glutathione status of plasma, liver and muscle following exhaustive exercise in rats. FEBS Lett 185,262-266[Medline]
  57. Davies, K. J., Quintanilha, A. T., Brooks, G. A., Packer, L. (1982) Free radicals and tissue damage produced by exercise. Biochem. Biophys. Res. Commun. 107,1198-1205[Medline]
  58. Reid, M. B., Shoji, T., Moody, M. R., Entman, M. L. (1992) Reactive oxygen in skeletal muscle. II. Extracellular release of free radicals. J. Appl. Physiol. 73,1805-1809[Abstract/Free Full Text]
  59. Supinski, G. (1998) Free radical induced respiratory muscle dysfunction. Mol. Cell. Biochem. 179,99-110[Medline]
  60. Hack, V., Gross, A., Kinscherf, R., Bockstette, M., Fiers, W., Berke, G., Dröge, W. (1996) Abnormal glutathione and sulfate levels after interleukin-6 treatment and in tumor-induced cachexia. FASEB J 10,1219-1226[Abstract]
  61. Vertechy, M., Cooper, M. B., Ghirardi, O., Ramacci, M. T. (1998) Antioxidant enzyme activities in heart and skeletal muscle of rats of different ages. Exp. Gerontol. 24,211-218
  62. Ji, L. L., Dillon, D., Wu, E. (1990) Alteration of antioxidant enzymes with aging in skeletal muscle and liver. Am. J. Physiol. 258,R918-R923[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. A. Potenza, F. Addabbo, and M. Montagnani
Vascular actions of insulin with implications for endothelial dysfunction
Am J Physiol Endocrinol Metab, September 1, 2009; 297(3): E568 - E577.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
N. Bashan, J. Kovsan, I. Kachko, H. Ovadia, and A. Rudich
Positive and Negative Regulation of Insulin Signaling by Reactive Oxygen and Nitrogen Species
Physiol Rev, January 1, 2009; 89(1): 27 - 71.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
E. Babilonia, D. Lin, Y. Zhang, Y. Wei, P. Yue, and W.-H. Wang
Role of gp91phox-Containing NADPH Oxidase in Mediating the Effect of K Restriction on ROMK Channels and Renal K Excretion
J. Am. Soc. Nephrol., July 1, 2007; 18(7): 2037 - 2045.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
Y. Wei, Z. Wang, E. Babilonia, H. Sterling, P. Sun, and W. Wang
Effect of hydrogen peroxide on ROMK channels in the cortical collecting duct
Am J Physiol Renal Physiol, April 1, 2007; 292(4): F1151 - F1156.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
E. Babilonia, D. Li, Z. Wang, P. Sun, D.-H. Lin, Y. Jin, and W.-H. Wang
Mitogen-Activated Protein Kinases Inhibit the ROMK (Kir 1.1)-Like Small Conductance K Channels in the Cortical Collecting Duct
J. Am. Soc. Nephrol., October 1, 2006; 17(10): 2687 - 2696.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Babilonia, Y. Wei, H. Sterling, P. Kaminski, M. Wolin, and W.-H. Wang
Superoxide Anions Are Involved in Mediating the Effect of Low K Intake on c-Src Expression and Renal K Secretion in the Cortical Collecting Duct
J. Biol. Chem., March 18, 2005; 280(11): 10790 - 10796.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. L. Schmitt, A. Hotz-Wagenblatt, H. Klein, and W. Droge
Interdependent Regulation of Insulin Receptor Kinase Activity by ADP and Hydrogen Peroxide
J. Biol. Chem., February 4, 2005; 280(5): 3795 - 3801.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
I. V. Turko and F. Murad
Protein Nitration in Cardiovascular Diseases
Pharmacol. Rev., December 1, 2002; 54(4): 619 - 634.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Hoyos, A. Imam, I. Korichneva, E. Levi, R. Chua, and U. Hammerling
Activation of c-Raf Kinase by Ultraviolet Light. REGULATION BY RETINOIDS
J. Biol. Chem., June 21, 2002; 277(26): 23949 - 23957.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
W. Droge
Free Radicals in the Physiological Control of Cell Function
Physiol Rev, January 1, 2002; 82(1): 47 - 95.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
V. J. Thannickal and B. L. Fanburg
Reactive oxygen species in cell signaling
Am J Physiol Lung Cell Mol Physiol, December 1, 2000; 279(6): L1005 - L1028.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H.-Y. Sohn, M. Keller, T. Gloe, H. Morawietz, U. Rueckschloss, and U. Pohl
The Small G-protein Rac Mediates Depolarization-induced Superoxide Formation in Human Endothelial Cells
J. Biol. Chem., June 16, 2000; 275(25): 18745 - 18750.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. J. Preston, W. J. Muller, and G. Singh
Scavenging of Extracellular H2O2 by Catalase Inhibits the Proliferation of HER-2/Neu-transformed Rat-1 Fibroblasts through the Induction of a Stress Response
J. Biol. Chem., March 16, 2001; 276(12): 9558 - 9564.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Mahadev, X. Wu, A. Zilbering, L. Zhu, J. T. R. Lawrence, and B. J. Goldstein
Hydrogen Peroxide Generated during Cellular Insulin Stimulation Is Integral to Activation of the Distal Insulin Signaling Cascade in 3T3-L1 Adipocytes
J. Biol. Chem., December 21, 2001; 276(52): 48662 - 48669.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SCHMID, E.
Right arrow Articles by DRÖGE, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SCHMID, E.
Right arrow Articles by DRÖGE, W.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS